Please login to the form below

Not currently logged in
Email:
Password:

Jounce Therapeutics

This page shows the latest Jounce Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bluebird and Celgene BCMA CAR-T kicks off ASCO

Bluebird and Celgene BCMA CAR-T kicks off ASCO

s lymphoma developed by Juno Therapeutics, which was acquired by Celgene earlier this year. ... That includes data on Jounce Therapeutics’ICOS-targeting antibody JTX-2011 which disappointed investors when the ASCO abstract was made public earlier this

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    $240m. Bayer. X-Chem. $528m. N/A. Topping the charts this month is the $2.6bn strategic collaboration deal that Celgene signed with Jounce Therapeutics for its platform and portfolio of ... Jounce Therapeutics/ Celgene. Portfolio and platform of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics